General Information of the Compound
Compound ID
CP0355585
Compound Name
N-(4-chlorophenyl)-2H-triazol-4-amine
    Show/Hide
Synonyms
C 82
C82
N-(4-Chlorophenyl)-2H-triazol-4-amine
SCHEMBL15831502
    Show/Hide
Structure
Formula
C8H7ClN4
Molecular Weight
194.625
Canonical SMILES
Clc1ccc(Nc2cn[nH]n2)cc1
    Show/Hide
InChI
InChI=1S/C8H7ClN4/c9-6-1-3-7(4-2-6)11-8-5-10-13-12-8/h1-5H,(H2,10,11,12,13)
    Show/Hide
InChIKey
IUTZKZLVPUPHDA-UHFFFAOYSA-N
Physicochemical Property
logP
2.2017
Rotatable Bonds
2
Heavy Atom Count
13
Polar Areas
53.6
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
13

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 75202656
ChEMBL ID
CHEMBL4443463
Clinical Information about the Compound
Drug 1 ( C 82 )
Drug Name C 82
Company PRISM Pharma Yokohama, Japan
Indication
Scleroderma
Phase 1/2
Target(s)
CREB-binding protein (CREBBP)
Inhibitor
Beta-catenin (CTNNB1)
Inhibitor